ENABLE (SHP643-402)

Category: Medical

ASO Keyword Dashboard

Tracking 2 keywords for ENABLE (SHP643-402) in Apple App Store

Developer: ERT,INC Category: medical

ENABLE (SHP643-402) tracks 2 keywords (2 keywords rank; full coverage across the tracked set). Key metrics: 50% top-10 coverage, opportunity 72.0, difficulty 43.3, best rank 2.

Tracked keywords

2 ranked • 0 not ranking yet

Top 10 coverage

50%

Best rank 2 • Latest leader 2

Avg opportunity

72.0

Top keyword: enable

Avg difficulty

43.3

Lower scores indicate easier wins

Opportunity leaders

enable

Opportunity: 72.0 • Difficulty: 43.6 • Rank 2

Competitors: 181
69.0
enables

Opportunity: 72.0 • Difficulty: 42.9 • Rank 30

Competitors: 72
70.9

Unranked opportunities

Every tracked keyword currently has some ranking data.

High competition keywords

enables

Total apps: 17,238 • Major competitors: 72

Latest rank: 30 • Difficulty: 42.9
enable

Total apps: 13,227 • Major competitors: 181

Latest rank: 2 • Difficulty: 43.6

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
enable	72	100	44	69 13,227 competing apps Median installs: 150 Avg rating: 4.1	2	2	181 major competitor apps
enables	72	100	43	71 17,238 competing apps Median installs: 100 Avg rating: 3.9	30	30	72 major competitor apps

Major Competitors

enable

100

13,227 competing apps

Median installs: 150

Avg rating: 4.1

181

major competitor apps

enables

100

17,238 competing apps

Median installs: 100

Avg rating: 3.9

major competitor apps

App Description

A three-year, non-interventional, prospective, multicenter study to evaluate the long-term effectiveness of lanadelumab in real-world clinical practice (ENABLE)